M3Nephron
Mixed-matrix adsorption–diffusion membranes for lower-resource dialysis
Technology
Company
A 2025-founded medtech venture developing mixed-matrix membranes that combine diffusion and adsorption in one dialyzer. The platform targets higher uremic-toxin clearance, lower dialysate consumption, and eventual wearable artificial-kidney applications.
About M3Nephron
M3Nephron B.V. is a 2025 spin-off from the University of Twente, Netherlands. The company focuses on the development and commercialization of innovative membrane technologies to improve hemodialysis treatment, aiming to enhance patient outcomes, reduce healthcare costs, and increase the accessibility of home-based and portable dialysis solutions.
Inquire about this partnering listing
Hidden Contact
Hidden Role
Industry applications
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.